Name and surname:
|
doc. MUDr. Tomáš Koller, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
associate professor of internal medicine | Lekárska fakulta Univerzity Komenského v Bratislave/Comenius University Faculty of Medicine | since 2010 as assistant, since 2016 as associate professsor |
gastroenterologist | Univerzitná nemocnica Bratislava | 2004-2010 |
internista | Univerzitná nemocnica Bratislava | 2001-2004 |
physician | Nemocnica Sv. Cyrila a Metoda | 1998-2001 |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
specialist in gastroenterology | Slovenská zdravotnícka univerzita | 2004 |
specialist in hepatology | Slovenská zdravotnícka univerzita | 2009 |
specialist in internal medicine | Lekárska fakulta Univerzity Komenského v Bratislave/Comenius University Faculty of Medicine | 2017 |
diploma "Attestation de formation specialiseé", 1 rok, Hepato-gastroenterológia | Univesité Pierre et Marie Curie (now Sorbonne Université), Paríž, Francúzsko | 2003-2004 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
internal medicine | general medicine | 2 | general medicine |
specialist diploma in gastroenterology, guarantor | gastroenterology | 3 | gastroenterology |
Koller T, Vrbova P, Kubanek N, Zilincanova D, Selcanova SA, Havaj DJ, Skladany L.
Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease.
United European Gastroenterol J. 2024 Jul 19. doi: 10.1002/ueg2.12633. Online ahead of print. PMID: 39031494
Skladany L, Koller T, Molcan P, Vnencakova J, Zilincan M, Jancekova D, Kukla M.
Prognostic usefulness of serum myostatin in advanced chronic liver disease: its relation to gender and correlation with inflammatory status.
J Physiol Pharmacol. 2019 Jun;70(3). doi: 10.26402/jpp.2019.3.03. Epub 2019 Sep 18. PMID: 31539882.
Skladany L, Molcan P, Vnencakova J, Vrbova P, Kukla M, Laffers L, Koller T.
Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis.
Can J Gastroenterol Hepatol. 2021 May 21;2021:5576531. doi: 10.1155/2021/5576531. eCollection 2021.PMID: 34095016
Koller T, Galambosova M, Filakovska S, Kubincova M, Hlavaty T, Toth J, Krajcovicova A, Payer J.
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.
World J Gastroenterol. 2017 Jun 14;23(22):4102-4111. doi: 10.3748/wjg.v23.i22.4102. PMID: 28652663; PMCID: PMC5473129.
Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J.
Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Scand J Gastroenterol. 2012 Feb;47(2):197-203. doi: 10.3109/00365521.2011.643481. Epub 2011 Dec 19. PMID: 22182015.
Koller T, Vrbova P, Kubanek N, Zilincanova D, Selcanova SA, Havaj DJ, Skladany L.
Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease.
United European Gastroenterol J. 2024 Jul 19. doi: 10.1002/ueg2.12633. Online ahead of print. PMID: 39031494
Skladaný Ľ, Líška D, Liptáková E, Tapajčiková T, Vnenčaková J, Koller T.
Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia.
Sci Rep. 2023 Feb 11;13(1):2463. doi: 10.1038/s41598-023-29510-2. PMID: 36774367; PMCID: PMC9918821.
Skladany L, Vnencakova J, Laffers L, Skvarkova B, Hrubá E, Molcan P, Koller T.
Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease.
Patient Prefer Adherence. 2021 Jan 5;14:2559-2572. doi: 10.2147/PPA.S283034. eCollection
Skladaný Ĺ, Žilinčanová D, Žilinčan M, Okapec S, Danček F, Adamcová-Selčanová S, Kukla M, Koller T.
Hepatic venous pressure gradient in patients with (compensated and decompensated) advanced chronic liver disease - A comparison of metabolic dysfunction-associated steatotic liver disease with alcohol-associated liver disease:
A retrospective view. PLoS One. 2025 Mar 5;20(3):e0317287. doi: 10.1371/journal.pone.0317287. PMID: 40043074; PMCID: PMC11882044.
Skladany L, Kubanek N, Adamcova Selcanova S, Zilincanova D, Havaj D, Sulejova K, Soltys K, Messingerova L, Lichvar M, Laffers L, Zilincan M, Honsova E, Liptak P, Banovcin P, Bures J, Koller T, Golubnitschaja O, Arab JP.
3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation.
EPMA J. 2024 Oct 31;15(4):677-692. doi: 10.1007/s13167-024-00381-5. PMID: 39635024; PMCID: PMC11612130.
Project SIRIUS, Slovak Society of Hepatology, mapping the prevalence of liver disease in Slovakia.
Cirrhosis registry in Slovakia, RH7
Member of the Global Expert Panel (GEP) in the Essence (NovoNordisk) clinical trial investigating the effect of semaglutide on metabolically associated steatotic liver disease
Scientific Secretary of the Slovak Hepatological Society since 2022 (www.slovhep.sk)
Member of the Committee and Treasurer of the Slovak Gastroenterological Society (2018-2022)
Deputy Editor-in-Chief for Slovakia of the journal Gastroenterology and Hepatology (https://www.csgh.info/cs/redakcni-rada)
Editor-in-Chief of the journal Trendy v Hepatology (https://trendyvhepatologii.sk/)
Founding member, guarantor, and member of the scientific committee of the event "Vnemy" intended for doctors in specialization training in the field of gastroenterology (www.vnemy.sk)